Search

Issue
Title
Authors
Modern drug therapy of prostate cancer through the example of Moscow
Polyakova K.I., Fisun A.G., Govorov A.V., Krysanova V.S., Andreev D.A., Ermolaeva T.N., Andreyashkina I.I., Zavyalov A.A., Davydovskaya M.V., Kokushkin K.A.
Drug treatment opportunities of the elderly patients with the metastatic castration-resistant prostate cancer
Solodkiy V.A., Pavlov A.Y., Gafanov R.A., Garmash S.V., Kravtsov I.V., Fastovets S.V., Ivashin A.K.
Modern approaches to treatment of castration-resistant prostate cancer using targeted radionuclide therapy in patients with bone metastases
Perepukhov V.M., Alekseev B.Y., Nyushko K.M.
Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM)
Alekseev B.Y., Anzhiganova Y.V., Sultanbaev A.V., Bystrov A.A., Orlov A.S., Gopp G.V., Kopyltsov A.V., Lykov A.V., Atduev V.A., Alekseeva G.N., Rodygin L.M., Varlamov S.A., Shestakov A.V., Maturov M.R., Urmantsev M.F., Lankina L.V., Parsadanova E.L., Startsev V.Y., Vedrova O.V., Andreev S.Y., Perevoshchikov A.A., Mailyan O.A., Kalpinskiy A.S.
Prevalence of mutations in DNA repair genes in Russian patients with metastatic castration-resistant prostate cancer
Mailyan O.A., Kalpinskiy A.S., Reshetov I.V., Anzhiganova Y.V., Nyushko K.M., Kaprin А.D., Golovashchenko M.P., Kokin S.P., Stakanov V.A., Alekseev B.Y.
Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer
Alekseev B.Y., Perepukhov V.M., Nyushko K.M.
Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer
Mailyan O.A., Kalpinskiy A.S., Reshetov I.V., Nyushko K.M., Alekseev B.Y., Kokin S.P., Stakanov V.A., Golovashchenko M.P.
Neuroendocrine prostate cancer
Safina S.Z., Isyangulova A.Z.
Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy
Nikolaeva E.A., Krylov A.S., Ryzhkov A.D., Geliashvili T.M., Pavlova A.V., Goryainova A.Y., Murashko R.A.
Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases
Matveev V.B., Markova A.S.
Metastatic castration-resistant prostate cancer and immune checkpoint inhibitors
Pavlov A.Y., Dzidzaria A.G., Gafanov R.A., Samusevich V.A., Mirzoev E.E., Kortyshkova A.O., Aivazov M.T., Mirzoev F.E.
Current opportunities of therapy for patients with non-metastatic castration-resistant prostate cancer
Alekseev B.Y., Nushko K.M., Kozlova P.S., Kaprin A.D., Mailyan O.I.
An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia
Alekseev B.Y., Nyushko K.M., Gafanov R.A., Kirichek A.A., Anzhiganova Y.V., Kopyltsov E.I., Sundui Y.Y., Matveev V.B.
Radionuclide therapy with radium-223 chloride. A few strokes to the patient’s portrait
Oschepkov V.N., Zotov P.B., Ismakov R.M., Khazimov A.M., Tukmanbetov I.D.
Prospects of 2nd line chemotherapy personalization in patients with metastatic castration-resistant prostate cancer
Alekseev B.Y., Nyushko K.M.
Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia
Alekseev B.Y., Nyushko K.M., Gafanov R.A., Kirichek A.A., Anzhiganova Y.V., Kopyltsov E.I., Sundui Y.Y., Pashanov Е.D., Petyushin A.N., Matveev V.B.
SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES
Markova A.S., Matveev V.B., Nazranov B.M.
Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
Markova A.S., Polikarpova S.B., Kamolov B.S., Gridneva Y.V., Kalinin S.A., Peters M.V., Matveev V.B.
Evaluation of the efficacy and safety of cabazitaxel in combination with prednisone in patients with metastatic castration-resistant prostate cancer who have previously received docetaxel chemotherapy in daily clinical practice. Results of a Russian multicenter prospective study
Alekseev B.Y., Shevchuk I.M.
THE POSSIBILITIES AND MECHANISMS OF ACTION OF HORMONE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
Alekseev B.Y., Andrianov A.N.
Impressive response to 177Lu-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer refractory to apalutamide, docetaxel and metastasis-directed therapy
Li A.A., Geliashvili T.M., Rumyantsev A.A., Pronin A.I., Krylov A.S., Baranova O.D., Parnas A.V., Ilyakov V.S., Vorobyeva D.A.
The National Registry of treatment regimens in patients with metastatic castration-resistant prostate cancer in the Russian Federation
Karyakin O.B., Kaprin A.D., Ivanov S.A.
Radium-223 systemic alpha-radiotherapy: targeted treatment of castration-resistant prostate cancer with bone metastases
Volkova М.I., Olshanskaya A.S.
1 - 23 of 23 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"